Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271583 · ClinicalTrials.gov registry record · Phase 2
Efficacy Trial of CDB 2914 for Emergency Contraception
A Phase 2 study of Emergency Contraception, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,672
- Enrollment target
- 6
- Study locations
NCT00271583 is a Phase 2 study of Emergency Contraception that has completed, run by University of Pittsburgh. The registered enrollment target is 1,672 participants, above the 1,148-participant average among 3 other Emergency Contraception trials with a reported enrollment target (46% higher). The trial reports 6 study locations across 6 states.
The verdict
NCT00271583, a Phase 2 study of Emergency Contraception, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,672 participants
- Enrollment target
- 6
- Study locations
Study Summary
Objective: To compare the efficacy, safety and tolerance of a 50 mg dose of a new antiprogestin, CDB-2914 with a 0.75 mg bid dose of levonorgestrel as emergency contraception Design: Multicenter, randomized, double blind Phase II study to compare a 50 mg dose of CDB-2914 to a 0.75 mg bid dose of levonorgestrel as emergency contraception Subjects are randomized to receive a one-time treatment with either one dose of 50 mg CDB-2914 (followed 12 hours later by a placebo) or 2 doses of 0.75 mg of levonorgestrel with follow-up visits at 5-7 days after expected onset of menses and another visit at 12-14 days after expected onset of menses (if needed) The primary aim is to evaluate the efficacy of CDB-2914 used by subjects as an emergency postcoital contraceptive in comparison to a group of subjects receiving levonorgestrel.
Conditions Studied
Interventions
- DRUG CDB-2914
- DRUG levonorgestrel
Study Locations (6)
California
- California Family Health Council - Los Angeles
Colorado
- University of Colorado - Denver
New York
- New York University - New York
Ohio
- University of Cincinnati - Cincinnati
Pennsylvania
- University of Pittsburgh - Pittsburgh
Virginia
- Eastern Virginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,672 participants |
| Start Date | 1999-09 |
| Est. Completion | 2001-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271583
The ClinicalTrials.gov registry entry for NCT00271583 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,672 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,148-participant average among 3 other Emergency Contraception trials with a reported enrollment target (46% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Emergency Contraception appearing as the primary indexed condition, and to 2 interventions - of which CDB-2914 is the first listed.
NCT00271583 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT00271583 about?
NCT00271583 is a clinical study titled "Efficacy Trial of CDB 2914 for Emergency Contraception". Objective: To compare the efficacy, safety and tolerance of a 50 mg dose of a new antiprogestin, CDB-2914 with a 0.75 mg bid dose of levonorgestrel as emergency contraception Design: Multicenter, randomized, double blind Phase II study to compare a 50 mg dose of CDB-2914 to a 0.75 mg bid dose of le...
What is the current status of trial NCT00271583?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,672 participants. The study started on 1999-09. Estimated completion is 2001-09.
What conditions does trial NCT00271583 study?
This clinical trial studies the following conditions: Emergency Contraception.
What interventions are being tested in trial NCT00271583?
The interventions under investigation include: CDB-2914 (DRUG), levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT00271583?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00271583 being conducted?
This trial has 6 study locations across California, Colorado, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergency Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.